This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Putnam, S. D.
Right arrow Articles by Frenck, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Putnam, S. D.
Right arrow Articles by Frenck, R. W.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2005, p. 2571-2572, Vol. 49, No. 6
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.6.2571-2572.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Posttreatment Changes in Escherichia coli Antimicrobial Susceptibility Rates among Diarrheic Patients Treated with Ciprofloxacin

Shannon D. Putnam,1* John W. Sanders,2 David R. Tribble,3 David R. Rockabrand,1 Mark S. Riddle,1 Patrick J. Rozmajzl,1 and Robert W. Frenck1

Naval Medical Research Unit 2, Jakarta, Indonesia,1 Naval Medical Research Unit 3, Cairo, Egypt,2 Naval Medical Research Center, Silver Spring, Maryland3

Received 23 November 2004/ Returned for modification 8 January 2005/ Accepted 21 February 2005

Changes in antimicrobial resistance of Escherichia coli among deployed U.S. military personnel being treated for diarrhea were evaluated. Stool samples were collected pretreatment and on days 7, 14, and 28 posttreatment. Resistance to ciprofloxacin was noted in 13.3% of baseline specimens, and rates of resistance against multiple antibiotics increased dramatically from baseline to day 7 and then tapered off to return to pretreatment levels by day 28, except for ciprofloxacin, suggesting that population accumulative usage of fluoroquinolones may result in an incremental increase in resistance rates.

* Corresponding author. Mailing address: U.S. Embassy Jakarta, NAMRU2 Box 8132, FPO AP 96520. Phone: 62 21 421 4457, ext. 1126. Fax: 62 21 420 7854. E-mail: Putnam{at}namru2.org.

Antimicrobial Agents and Chemotherapy, June 2005, p. 2571-2572, Vol. 49, No. 6
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.6.2571-2572.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Launay, E., Joram, N., Jacqueline, C., Miegeville, A. F., Caillon, J., Potel, G., Roze, J. C., Gras-Le Guen, C. (2009). Efficacy of Ciprofloxacin in an Experimental Model of Escherichia coli Chorioamnionitis in Rabbits. Antimicrob. Agents Chemother. 53: 1624-1627 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»